ERIN ZAPALAC: Open Payments
NPI 1316446818 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$306 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $174 · 2025 $306
Food & beverage: $306
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $229 |
| Boston Scientific Corporation | 1 | $23 |
| Biosense Webster, Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Amgen Inc. | 1 | $16 |
Products named: Wegovy, Ozempic, WATCHMAN FLX, CARTO 3, ELIQUIS, REPATHA.
Industry payments across TX — which companies pay providers there.
